IM Cannabis Corp. Designates New CEO to Propel Tech-Focused Growth Strategy

Leadership Change at IM Cannabis Corp.



In a strategic move aimed at enhancing its operations within the technology-driven sector, IM Cannabis Corp. announced a pivotal leadership change. Effective November 19, 2026, Ronen Zalayet has been appointed as the Chief Executive Officer, succeeding Oren Shuster, who has stepped down from his role.

Background of the New CEO



Ronen Zalayet brings a wealth of experience to IM Cannabis, having accumulated over 25 years in financial leadership roles across both private and public companies. His past positions include serving as the Chief Financial Officer of Nexera Technologies Ltd., where he worked since October 2022, and as the Chief Executive Officer of Shemen Oil and Gas Resources Ltd. Zalayet’s educational background is equally impressive, holding both a Bachelor’s degree in Economics and Accounting and an M.B.A. from Tel Aviv University, along with certification as a public accountant in Israel.

The Board expressed gratitude to Mr. Shuster for his contributions since the Company's inception and looks forward to the innovations and strategic initiatives that Mr. Zalayet will undoubtedly bring to the company.

Complementary Management Changes



In addition to Zalayet’s appointment, Shakked Shuster has taken on the role of CEO for Focus Medical Herbs Ltd., the company’s Israeli subsidiary. Shakked Shuster has six years of in-depth experience in the medical cannabis sector, playing a key role in areas such as product development and brand marketing during his tenure at IM Cannabis. He previously managed product standards and collaborated with Canadian producers to establish a supply chain from Canada to Israel. His understanding of the industry's landscape positions him well to drive the Israeli operations forward.

Board Reconfiguration



Alongside these management shifts, the IM Cannabis board has gone through further changes. Oren Shuster will remain involved as a director for the Israeli subsidiaries despite resigning from his role on the main board. Meanwhile, Ohad Melnik has been appointed as an independent director, subject to the approval of the Israel Medical Cannabis Agency. Melnik brings extensive experience as a former director with various entities, including Formula Systems and iFOREX Group, and holds degrees in Business Administration and Finance.

Commitment to Technology-Driven Initiatives



IM Cannabis Corp. has emphasized its goal of expanding beyond its core medical cannabis operations, with an eye on building a technology-focused business model. The company’s advancements in technology will be critical in enhancing their service delivery and patient care through improved data insights and operational efficiencies.

The shift to a technology-driven strategy aligns with current industry trends emphasizing digital transformation and innovation in patient services. As medical cannabis becomes increasingly competitive, IM Cannabis is positioning itself to not only meet current demands but to lead in the emerging market through applied technology.

Conclusion



These leadership changes mark an exciting period for IM Cannabis Corp. as it steers towards a future defined by technology and innovation in the cannabis sector. The new CEO, along with strategic appointments in management and the board, reflects the company's commitment to adapting and thriving in a fast-evolving landscape. With robust leadership and a clear vision, IM Cannabis is poised for significant growth and expansion in the coming years.

Topics Business Technology)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.